Influenza Vaccine Market - Forecast(2019 - 2024)

Report Code: HCR 0226 Report Format: PDF + Excel Database
Influenza vaccines are the vaccines which are applied to protect against influenza and is also known as influenza shots in the many parts of the world. This vaccine is a combination of three influenza viruses namely, influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain and influenza type B virus strain.

This report identifies the influenza vaccine market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to influenza vaccine market.

Influenza Vaccine Market

Globally North America dominated the market for influenza vaccine in 2015 with highest market share due to higher awareness about impacts of influenza and its outbreaks amongst its citizen coupled with developed medical and healthcare establishment in the region. North America was followed by Asia-Pacific and Europe as the second and third largest regional market respectively, for influenza vaccine. However, Asia-Pacific is expected to be fastest growing regional segment during the period of study due to fast growing healthcare setup in the region especially in India and China along with growing awareness about the influenza in the region.
  • This report on global influenza vaccine covers different type of influenza vaccine based vaccine type and also classifies the global influenza market based on the target group, and end-use industries and market size in various geographical regions.
  • On the basis of delivery method of the influenza vaccine, this report is segmented into two major segments as follows: Nasal Spray and Injection
  • This reports is also classified on the basis of age group and medical condition of the target audience, based on this global influenza market is classified into four major segments as follows: Infants, Children, Adults (Pregnant Women and Others) and Elderly People
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for influenza vaccine  in each of the region.

This report identifies all the major companies operating in the global influenza vaccine market. Some of the major companies’ profiles in detail are as follows:
  • Sanofi-pasteur
  • Novartis Inc.
  • GlaxoSmithKline
  • Abott Laboratories
  • Pfizer Inc.
1. Influenza Vaccine Market - Overview
1.1. Definitions and Scope
2. Influenza Vaccine Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Influenza Vaccine Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Influenza Vaccine Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Influenza Vaccine Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Influenza Vaccine Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Influenza Vaccine Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Influenza Vaccine Market – By Vaccine Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Injection
8.3.2. Nasal Spray
9. Influenza Vaccine Market – By Target Group (Market Size -$Million / $Billion)
9.1. Infants
9.2. Children
9.3. Adults
9.3.1. Pregnant Women
9.3.2. Others
9.4. Elderly People
10. Influenza Vaccine - By Geography (Market Size -$Million / $Billion)
10.1. Influenza Vaccine Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Influenza Vaccine - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Influenza Vaccine - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Influenza Vaccine – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Influenza Vaccine Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Influenza Vaccine Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
13.1.6. Best Practises for companies
13. Influenza Vaccine Market – Key Company List by Country Premium
14. Influenza Vaccine Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Sanofi-pasteur
14.3. Novartis Inc
14.4. GlaxoSmithKline
14.5. Abott Laboratories
14.6. Pfizer Inc
14.7. CSL
14.8. Hualan Bio
14.9. Changchun Bio
14.10. Fluarix & Flulaval
14.11. MedImmune
14.12. Company 10
14.13. Company 10
14.14. Company 10
14.15. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Influenza Vaccine Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Influenza Vaccine Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables:

Table 1: Influenza Vaccine Market Overview 2019-2024
Table 2: Influenza Vaccine Market Leader Analysis 2018-2019 (US$)
Table 3: Influenza Vaccine Market Product Analysis 2018-2019 (US$)
Table 4: Influenza Vaccine Market End User Analysis 2018-2019 (US$)
Table 5: Influenza Vaccine Market Patent Analysis 2013-2018* (US$)
Table 6: Influenza Vaccine Market Financial Analysis 2018-2019 (US$)
Table 7: Influenza Vaccine Market Driver Analysis 2018-2019 (US$)
Table 8: Influenza Vaccine Market Challenges Analysis 2018-2019 (US$)
Table 9: Influenza Vaccine Market Constraint Analysis 2018-2019 (US$)
Table 10: Influenza Vaccine Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Influenza Vaccine Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Influenza Vaccine Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Influenza Vaccine Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Influenza Vaccine Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Influenza Vaccine Market Value Chain Analysis 2018-2019 (US$)
Table 16: Influenza Vaccine Market Pricing Analysis 2019-2024 (US$)
Table 17: Influenza Vaccine Market Opportunities Analysis 2019-2024 (US$)
Table 18: Influenza Vaccine Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Influenza Vaccine Market Supplier Analysis 2018-2019 (US$)
Table 20: Influenza Vaccine Market Distributor Analysis 2018-2019 (US$)
Table 21: Influenza Vaccine Market Trend Analysis 2018-2019 (US$)
Table 22: Influenza Vaccine Market Size 2018 (US$)
Table 23: Influenza Vaccine Market Forecast Analysis 2019-2024 (US$)
Table 24: Influenza Vaccine Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Influenza Vaccine Market, Revenue & Volume, By Vaccine Type, 2019-2024 ($)
Table 26: Influenza Vaccine Market By Vaccine Type, Revenue & Volume, By Injection, 2019-2024 ($)
Table 27: Influenza Vaccine Market By Vaccine Type, Revenue & Volume, By Nasal Spray, 2019-2024 ($)
Table 28: Influenza Vaccine Market, Revenue & Volume, By Target Group, 2019-2024 ($)
Table 29: Influenza Vaccine Market By Target Group, Revenue & Volume, By Infants, 2019-2024 ($)
Table 30: Influenza Vaccine Market By Target Group, Revenue & Volume, By Children, 2019-2024 ($)
Table 31: Influenza Vaccine Market By Target Group, Revenue & Volume, By Adults, 2019-2024 ($)
Table 32: Influenza Vaccine Market By Target Group, Revenue & Volume, By Pregnant Women, 2019-2024 ($)
Table 33: Influenza Vaccine Market By Target Group, Revenue & Volume, By Elderly People, 2019-2024 ($)
Table 34: North America Influenza Vaccine Market, Revenue & Volume, By Vaccine Type, 2019-2024 ($)
Table 35: North America Influenza Vaccine Market, Revenue & Volume, By Target Group, 2019-2024 ($)
Table 36: South america Influenza Vaccine Market, Revenue & Volume, By Vaccine Type, 2019-2024 ($)
Table 37: South america Influenza Vaccine Market, Revenue & Volume, By Target Group, 2019-2024 ($)
Table 38: Europe Influenza Vaccine Market, Revenue & Volume, By Vaccine Type, 2019-2024 ($)
Table 39: Europe Influenza Vaccine Market, Revenue & Volume, By Target Group, 2019-2024 ($)
Table 40: APAC Influenza Vaccine Market, Revenue & Volume, By Vaccine Type, 2019-2024 ($)
Table 41: APAC Influenza Vaccine Market, Revenue & Volume, By Target Group, 2019-2024 ($)
Table 42: Middle East & Africa Influenza Vaccine Market, Revenue & Volume, By Vaccine Type, 2019-2024 ($)
Table 43: Middle East & Africa Influenza Vaccine Market, Revenue & Volume, By Target Group, 2019-2024 ($)
Table 44: Russia Influenza Vaccine Market, Revenue & Volume, By Vaccine Type, 2019-2024 ($)
Table 45: Russia Influenza Vaccine Market, Revenue & Volume, By Target Group, 2019-2024 ($)
Table 46: Israel Influenza Vaccine Market, Revenue & Volume, By Vaccine Type, 2019-2024 ($)
Table 47: Israel Influenza Vaccine Market, Revenue & Volume, By Target Group, 2019-2024 ($)
Table 48: Top Companies 2018 (US$)Influenza Vaccine Market, Revenue & Volume
Table 49: Product Launch 2018-2019Influenza Vaccine Market, Revenue & Volume
Table 50: Mergers & Acquistions 2018-2019Influenza Vaccine Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Influenza Vaccine Market 2019-2024
Figure 2: Market Share Analysis for Influenza Vaccine Market 2018 (US$)
Figure 3: Product Comparison in Influenza Vaccine Market 2018-2019 (US$)
Figure 4: End User Profile for Influenza Vaccine Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Influenza Vaccine Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Influenza Vaccine Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Influenza Vaccine Market 2018-2019
Figure 8: Ecosystem Analysis in Influenza Vaccine Market 2018
Figure 9: Average Selling Price in Influenza Vaccine Market 2019-2024
Figure 10: Top Opportunites in Influenza Vaccine Market 2018-2019
Figure 11: Market Life Cycle Analysis in Influenza Vaccine Market
Figure 12: GlobalBy Vaccine TypeInfluenza Vaccine Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Target GroupInfluenza Vaccine Market Revenue, 2019-2024 ($)
Figure 14: Global Influenza Vaccine Market - By Geography
Figure 15: Global Influenza Vaccine Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Influenza Vaccine Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 18: US Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 93: China Influenza Vaccine Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Influenza Vaccine Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Influenza Vaccine Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Influenza Vaccine Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Influenza Vaccine Market
Figure 131: Developments, 2018-2019*Influenza Vaccine Market
Figure 132: Company 1 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Influenza Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Influenza Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Influenza Vaccine Market Net Sales Share, By Geography, 2018 (%)